Maria Jure‐Kunkel
Bristol-Myers Squibb (United States)
1 paper in the Anchorcite directory, published in 2012, cited 12,793 times in total.
ORCID profileResearch topics
- T-cell and B-cell Immunology · 1 paper
- Cancer Immunotherapy and Biomarkers · 1 paper
- Immunotherapy and Immune Responses · 1 paper
Frequent co-authors
- Suzanne Louise Topalian · 1 paper
- Frank Stephen Hodi · 1 paper
- Julie Renee Brahmer · 1 paper
- Scott N. Gettinger · 1 paper
- David Carl Smith · 1 paper
- David F. McDermott · 1 paper
- John D. Powderly · 1 paper
- Richard D. Carvajal · 1 paper
Papers
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine · 2012 · 12,793 citations
BACKGROUND: Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1. METHODS: We enrolled patients with advanced melanoma,…
Metadata from OpenAlex (CC0).